AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers

Jing Xin,1,* Sijia Wang,1,* Bing Wang,1 Jiazhuang Wang,1 Jing Wang,1 Luwei Zhang,1 Bo Xin,2 Lijian Shen,1 Zhenxi Zhang,1 Cuiping Yao1 1Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute of Biomedical Analytical Technology and Instrumentation, School of Life Scienc...

Full description

Bibliographic Details
Main Authors: Xin J, Wang SJ, Wang B, Wang JZ, Wang J, Zhang LW, Xin B, Shen LJ, Zhang ZX, Yao CP
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/alpcs4-pdt-for-gastric-cancer-therapy-using-gold-nanorod-cationic-lipo-peer-reviewed-article-IJN
_version_ 1818744398967472128
author Xin J
Wang SJ
Wang B
Wang JZ
Wang J
Zhang LW
Xin B
Shen LJ
Zhang ZX
Yao CP
author_facet Xin J
Wang SJ
Wang B
Wang JZ
Wang J
Zhang LW
Xin B
Shen LJ
Zhang ZX
Yao CP
author_sort Xin J
collection DOAJ
description Jing Xin,1,* Sijia Wang,1,* Bing Wang,1 Jiazhuang Wang,1 Jing Wang,1 Luwei Zhang,1 Bo Xin,2 Lijian Shen,1 Zhenxi Zhang,1 Cuiping Yao1 1Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute of Biomedical Analytical Technology and Instrumentation, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, Shaanxi, China; 2School of Innovation and Entrepreneurship, Xi’an Fan Yi University, Xi’an, Shaanxi, China *These authors contributed equally to this work Purpose: As a promising photodynamic therapy (PDT) agent, Al(III) phthalocyanine chloride tetrasulfonic acid (AlPcS4) provides deep penetration into tissue, high quantum yields, good photostability, and low photobleaching. However, its low delivery efficiency and high binding affinity to serum albumin cause its low penetration into cancer cells, further limiting its PDT effect on gastric cancer. In order to improve AlPcS4/PDT effect, the AlPcS4 delivery sys­tems with different drug carriers were synthesized and investigated. Materials and methods: Gold nanorods, cationic liposomes, and Pluronic® F127 nanomicellars were used to formulate the AlPcS4 delivery systems. The anticancer effect was evaluated by CCK-8 assay and colony formation assay. The delivery efficiency of AlPcS4 and the binding affinity to serum proteins were determined by fluorescence intensity assay. The apoptosis and necrosis ability, reactive oxygen species and singlet oxygen generation, mitochondrial transmembrane potential and ([Ca2+]i) concentration were further measured to evaluate the mechanism of cell death. Results: The series of synthesized AlPcS4 delivery sys­tems with different drug carriers improve the limited PDT effect in varying degrees. In contrast, AlPcS4 complex with gold nanorods has significant anticancer effects because gold nanorods are not only suitable for AlPcS4 delivery, but also exhibit enhanced singlet oxygen generation effect and photothermal effect to induce cell death directly. Moreover, AlPcS4 complex with cationic liposomes shows the potent inhibition effect because of its optimal AlPcS4 delivery efficiency and ability to block serum albumin. In addition, AlPcS4 complex with Pluronic F127 exhibits infe­rior PDT effect but presents lower cytotoxicity, slower dissociation rate, and longer retention time of incorporated drugs; thus, F127–AlPcS4 is used for prolonged gastric cancer therapy. Conclusion: The described AlPcS4 drug delivery systems provide promising agents for gastric cancer therapy. Keywords: drug delivery carriers, AlPcS4, gastric cancer therapy, gold nanoparticles, cationic liposome, nanomicelle
first_indexed 2024-12-18T02:43:41Z
format Article
id doaj.art-c149d5c5ea0e4d548d4a057011ae1ea2
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-18T02:43:41Z
publishDate 2018-04-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-c149d5c5ea0e4d548d4a057011ae1ea22022-12-21T21:23:36ZengDove Medical PressInternational Journal of Nanomedicine1178-20132018-04-01Volume 132017203637567AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriersXin JWang SJWang BWang JZWang JZhang LWXin BShen LJZhang ZXYao CPJing Xin,1,* Sijia Wang,1,* Bing Wang,1 Jiazhuang Wang,1 Jing Wang,1 Luwei Zhang,1 Bo Xin,2 Lijian Shen,1 Zhenxi Zhang,1 Cuiping Yao1 1Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute of Biomedical Analytical Technology and Instrumentation, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an, Shaanxi, China; 2School of Innovation and Entrepreneurship, Xi’an Fan Yi University, Xi’an, Shaanxi, China *These authors contributed equally to this work Purpose: As a promising photodynamic therapy (PDT) agent, Al(III) phthalocyanine chloride tetrasulfonic acid (AlPcS4) provides deep penetration into tissue, high quantum yields, good photostability, and low photobleaching. However, its low delivery efficiency and high binding affinity to serum albumin cause its low penetration into cancer cells, further limiting its PDT effect on gastric cancer. In order to improve AlPcS4/PDT effect, the AlPcS4 delivery sys­tems with different drug carriers were synthesized and investigated. Materials and methods: Gold nanorods, cationic liposomes, and Pluronic® F127 nanomicellars were used to formulate the AlPcS4 delivery systems. The anticancer effect was evaluated by CCK-8 assay and colony formation assay. The delivery efficiency of AlPcS4 and the binding affinity to serum proteins were determined by fluorescence intensity assay. The apoptosis and necrosis ability, reactive oxygen species and singlet oxygen generation, mitochondrial transmembrane potential and ([Ca2+]i) concentration were further measured to evaluate the mechanism of cell death. Results: The series of synthesized AlPcS4 delivery sys­tems with different drug carriers improve the limited PDT effect in varying degrees. In contrast, AlPcS4 complex with gold nanorods has significant anticancer effects because gold nanorods are not only suitable for AlPcS4 delivery, but also exhibit enhanced singlet oxygen generation effect and photothermal effect to induce cell death directly. Moreover, AlPcS4 complex with cationic liposomes shows the potent inhibition effect because of its optimal AlPcS4 delivery efficiency and ability to block serum albumin. In addition, AlPcS4 complex with Pluronic F127 exhibits infe­rior PDT effect but presents lower cytotoxicity, slower dissociation rate, and longer retention time of incorporated drugs; thus, F127–AlPcS4 is used for prolonged gastric cancer therapy. Conclusion: The described AlPcS4 drug delivery systems provide promising agents for gastric cancer therapy. Keywords: drug delivery carriers, AlPcS4, gastric cancer therapy, gold nanoparticles, cationic liposome, nanomicellehttps://www.dovepress.com/alpcs4-pdt-for-gastric-cancer-therapy-using-gold-nanorod-cationic-lipo-peer-reviewed-article-IJNdrug delivery carriersAlPcS4gastric cancer therapygold nanoparticlescationic liposomenano-micelle
spellingShingle Xin J
Wang SJ
Wang B
Wang JZ
Wang J
Zhang LW
Xin B
Shen LJ
Zhang ZX
Yao CP
AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
International Journal of Nanomedicine
drug delivery carriers
AlPcS4
gastric cancer therapy
gold nanoparticles
cationic liposome
nano-micelle
title AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
title_full AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
title_fullStr AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
title_full_unstemmed AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
title_short AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
title_sort alpcs4 pdt for gastric cancer therapy using gold nanorod cationic liposome and pluronic reg f127 nanomicellar drug carriers
topic drug delivery carriers
AlPcS4
gastric cancer therapy
gold nanoparticles
cationic liposome
nano-micelle
url https://www.dovepress.com/alpcs4-pdt-for-gastric-cancer-therapy-using-gold-nanorod-cationic-lipo-peer-reviewed-article-IJN
work_keys_str_mv AT xinj alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT wangsj alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT wangb alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT wangjz alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT wangj alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT zhanglw alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT xinb alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT shenlj alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT zhangzx alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers
AT yaocp alpcs4pdtforgastriccancertherapyusinggoldnanorodcationicliposomeandpluronicregf127nanomicellardrugcarriers